By Professor David Goldstein

Journal articles

Goldstein D; Underhill CR; Olver IN; Kosczwara ; Kay F; Franca M, 2010, 'Reaching Further with Online Education? The Development of an Effective Online Program in Palliative Oncology', Journal of Cancer Education, 25, pp. 317 - 323

Wolf M; Kneebone AB; Goldstein D; Joseph D; Wirth A; Grigg A; Johnson C; Davis S, 2010, 'Risk and Response Adapted Therapy for Early Stage Hodgkin Lymphoma: A Prospective Multi-Centre Study of the Australasian Leukaemia and Lymphoma Group/Trans-Tasman Radiation Oncology Group', Leukemia and Lymphoma, 52, pp. 786 - 795, http://dx.doi.org/10.3109/10428194.2010.547155

Xu ZH; Vonlaufen A; Phillips PA; Fiala-Beer E; Zhang X; Yang L; Biankin AV; Goldstein D; Pirola R; Wilson JS; Apte MV, 2010, 'Role of pancreatic stellate cells in pancreatic cancer metastasis', American Journal of Pathology, 177, pp. 2585 - 2596, http://linkinghub.elsevier.com/retrieve/pii/S0002-9440(10)60308-2

Goldstein D; Harris C; Harris C, 2010, 'Tamoxifen use in retroperitoneal fibrosis, case report and review of the literature', Internal Medicine Journal, 40, pp. e5 - e7

Harris C; Goldstein D, 2010, 'Tamoxifen use in retroperitoneal fibrosis.', Intern Med J, 40, pp. e5 - e7, http://dx.doi.org/10.1111/j.1445-5994.2010.02373.x

Rossleigh MA; Goldstein D, 2010, 'Treatment of Fluorouracil-Refractory Patients with Liver Metastases from Colorectal Cancer by Using Yttrium-90 Resin Microspheres Plus Concomitant Systemic Irinotecan Chemotherapy', Journal of Clinical Oncology, 27, pp. 4089 - 4095

Xu Z; Phillips PA; Vonlaufen A; Fiala-Beer E; Yang L; Biankin A; Goldstein D; Pirola R; Wilson J; Apte M, 2009, 'Normal Pancreatic Stellate Cells Facilitate Pancreatic Cancer Progression, Exhibit Transendothelial Migration and Accompany Cancer Cells to Distant Metastatic Sites', PANCREAS, 38, pp. 1062 - 1062, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000271225300403&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Neoptolemos J; Büchler M; Stocken DD; Ghaneh P; Smith D; Bassi C; Moore M; Cunningham D; Dervenis C; Goldstein D, 2009, 'ESPAC-3(v2): A multicenter, international, open-label, randomized, controlled phase III trial of adjuvant 5-fluorouracil/folinic acid (5-FU/FA) versus gemcitabine (GEM) in patients with resected pancreatic ductal adenocarcinoma', Journal of Clinical Oncology, 27, pp. LBA4505 - LBA4505, http://dx.doi.org/10.1200/jco.2009.27.18s.lba4505

Neoptolemos J; Büchler M; Stocken DD; Ghaneh P; Smith D; Bassi C; Moore M; Cunningham D; Dervenis C; Goldstein D, 2009, 'ESPAC-3(v2): A multicenter, international, open-label, randomized, controlled phase III trial of adjuvant 5-fluorouracil/folinic acid (5-FU/FA) versus gemcitabine (GEM) in patients with resected pancreatic ductal adenocarcinoma', Journal of Clinical Oncology, 27, pp. LBA4505 - LBA4505, http://dx.doi.org/10.1200/jco.2009.27.18_suppl.lba4505

Neoptolemos J; Büchler M; Stocken DD; Ghaneh P; Smith D; Bassi C; Moore M; Cunningham D; Dervenis C; Goldstein D, 2009, 'ESPAC-3(v2): A multicenter, international, open-label, randomized controlled phase III trial of adjuvant 5-fluorouracil/folinic acid (5-FU/FA) versus gemcitabine (GEM) in patients with resected pancreatic ductal adenocarcinoma', Journal of Clinical Oncology, 27, pp. LBA4505 - LBA4505, http://dx.doi.org/10.1200/jco.2009.27.15_suppl.lba4505

Goldstein D; van Hazel G; Selva-Nayagam S; Ackland S; Shapiro J; Carroll S; Cummins M; Brown C; Simes RJ; Spry N, 2009, 'GOFURTGO trial (GFG): An AGITG multicenter phase II study of fixed dose rate gemcitabine-oxaliplatin (Gem-Ox) integrated with concomitant 5FU and 3-D conformal radiotherapy (5FU-3DRT) for the treatment of locally advanced pancreatic cancer (LAPC).', J Clin Oncol, 27, pp. 4616, http://www.ncbi.nlm.nih.gov/pubmed/27964183

Phillips P; Chow MW; Vonlaufen A; Xu Z; Yang L; Biankin A; Goldstein D; Pirola R; Wilson J; Apte M, 2009, 'Gene expression profiling of human pancreatic stellate cells and their roles in pancreatic cancer progression.', CANCER RESEARCH, 69, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000209702804198&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Phillips P; Yang L; Vonlaufen A; Xu Z; Biankin A; Goldstein D; Pirola R; Wilson J; Apte M, 2009, 'Heat shock proteins are induced during pancreatic stellate cell activation in pancreatic cancer', CANCER RESEARCH, 69, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000209702804197&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Lee CK; Hadley A; Desilva K; Smith G; Goldstein D, 2009, 'When is a GIST not a GIST? A case report of synchronous metastatic gastrointestinal stromal tumor and fibromatosis.', World J Surg Oncol, 7, pp. 8, http://dx.doi.org/10.1186/1477-7819-7-8

Yip D; Karapetis C; Strickland A; Steer CB; Goldstein D, 2009, 'WITHDRAWN: Chemotherapy and radiotherapy for inoperable advanced pancreatic cancer.', Cochrane database of systematic reviews (Online)

Park SB; Goldstein D; Lin CS; Krishnan AV; Friedlander ML; Kiernan MC, 2009, 'Acute abnormalities of sensory nerve function associated with oxaliplatin-induced neurotoxicity', Journal of clinical oncology - official journal of the American Society of Clinical Oncology, 27, pp. 1243 - 1249

Girgis A; Hansen V; Goldstein D, 2009, 'Are Australian oncology health professionals burning out? A view from the trenches', European Journal of Cancer, 45, pp. 393 - 399

Girgis A; Hansen V; Goldstein D, 2009, 'Are Australian oncology health professionals burning out? A view from the trenches', European Journal of Cancer, 45, pp. 393 - 399

Steer C; Marx GM; Singhal N; Mcjannett M; Prowse R; Goldstein D, 2009, 'Cancer in the older adult: a tale of two disciplines', Journal of Internal Medicine, 39, pp. 771 - 775

Underhill CR; Bartel R; Goldstein D; Snodgrass H; Begbie S; Yates P; White K; Jong K; Grogan P, 2009, 'Mapping oncology services in regional and rural Australia', Australian Journal of Rural Health, 17, pp. 321 - 329, http://dx.doi.org/10.1111/j.1440-1584.2009.01106.x

Chua W; Goldstein D; Dhillon H; Mitchell P; Clarke SJ; Iacopetta BJ; Lee CK; Michael M, 2009, 'Molecular markers of response and toxicity to FOLFOX chemotherapy in metastatic colorectal cancer', British Journal of Cancer, 101, pp. 998 - 1004, http://dx.doi.org/10.1038/sj.bjc.6605239

Park SB; Lin CS-Y; Krishnan AV; Goldstein D; Friedlander ML; Kiernan MC, 2009, 'Oxaliplatin-induced Lhermitte’s phenomenon as a manifestation of severe generalized nerve dysfunction', Oncology, 77, pp. 342 - 348

Park SB; Lin CS; Krishnan AV; Goldstein D; Friedlander ML; Kiernan MC, 2009, 'Oxaliplatin-induced neurotoxicity: Changes in axonal excitability precede development of neuropathy', Brain, 132, pp. 2712 - 2723

Torda AJ, 2009, 'Response', Journal of Bioethical Inquiry, 6, pp. 257 - 258

Pranavan G; Goldstein D; Yip D, 2009, 'Response of Carney`s triad-related metastatic gastrointestinal stromal tumor to sunitinib', Asia-Pacific Journal of Clinical Oncology, 4, pp. 170 - 174

Phillips P; Yang L; Vonlaufen A; Xu Z; Biankin AV; Goldstein D; Pirola R; Wilson JS; Apte MV, 2009, 'S1820 Heat Shock Proteins Are Induced During Pancreatic Stellate Cell Activation in Pancreatic Cancer', Gastroenterology, 136, pp. A - 277, http://dx.doi.org/10.1016/s0016-5085(09)61262-2

Tan TH; Hemmings C; Stafford-bell M; Robson S; Goldstein D; Yip D, 2009, 'The successful management of two pregnancies with wild type metastatic gastrointestinal stromal tumors', Asia-Pacific Journal of Clinical Oncology, 5, pp. 187 - 192

Goldstein D; Van Hazel GA; Pavlakis N, 2009, 'Treatment of 5-Fluorouracil-Refractory Patients With Liver Metastases From Colorectal Cancer Using Yttrium-90 Resin Microspheres Plus Concomitant Systemic Irinotecan Chemotherapy', Journal of Clinical Oncology, 27, pp. 4085 - 4095

Lee CK; Hadley A; Desilva K; Goldstein D, 2009, 'When is a GIST not a GIST? A case report of synchronous metastatic gastrointestinal stromal tumor and fibromatosis', World Journal of Surgical Oncology, 7, pp. 1 - 4

Alvaro F; Young A; Goldstein D; Thomas D; McJannett M; Dillon R, 2008, 'Clinical oncological society of Australia: Adolescent and young adult cancer forum', Cancer Forum, 32, pp. 116 - 119

Goldstein D; Bennett B; Cameron B; Boyle F; DeSouza P; Wilcken N; Friedlander M; Scott E; Hickie I; Lloyd AAM, 2008, 'A prospective cohort study of fatigue after adjuvant therapy for breast cancer: Association with hematologic, endocrine, and immune parameters', JOURNAL OF CLINICAL ONCOLOGY, 26, http://dx.doi.org/10.1200/jco.2008.26.15_suppl.9596

Blinman PL; Duric VM; Nowak AK; Beale P; Clarke SJ; Briscoe K; Boyce A; Goldstein D; Hudson M; Stockler MR, 2008, 'Patients' preferences for adjuvant chemotherapy (ACT) in early colon cancer (ECC): What makes it worthwhile?', JOURNAL OF CLINICAL ONCOLOGY, 26, http://dx.doi.org/10.1200/jco.2008.26.15_suppl.4050

Spry N; Macleod C; Borg M; Ngan SY; Millar J; Graham PH; Zissiadis Y; Kneebone AB; Carroll SL; Davies T; Reece W; Iacopetta BJ; Goldstein D; Harvey JE, 2008, '3D radiotherapy can be safely combined with sandwich systemic gemcitabine chemotherapy in the management of pancreatic cancer: Factors influencing outcome', International Journal of Radiation Oncology and Biology Physics, 70, pp. 1438 - 1446, http://dx.doi.org/10.1016/j.ijrobp.2007.08.070

Lin CS-Y; Krishnan A; Goldstein D; Friedlander M; Kiernan M, 2008, '457: Sensory nerve excitability in cancer patients treated with oxaliplatin', Journal of Clinical Neuroscience, 15, pp. 362 - 362, http://dx.doi.org/10.1016/j.jocn.2007.07.067

Shepherd LM; Goldstein D; Olver IN; Parle MD, 2008, 'Enhancing psychosocial care for people with cancer in rural communities: what can remote counselling offer?', Australian Health Review, 32, pp. 423 - 438

Vonlaufen A; Phillips PA; Xu ZH; Goldstein D; Pirola RC; Wilson JS; Apte MV, 2008, 'Lending a helping hand: Role of pancreatic stellate in pancreatic cancer', Cancer Research, 68, pp. 7707 - 7710

Park SB; Krishnan AV; Lin CS; Goldstein D; Friedlander ML; Kiernan MC, 2008, 'Mechanisms underlying chemotherapy-induced neurotoxicity and the potential for neuroprotective strategies', Current Medicinal Chemistry: Cardiovascular and Hematological Agents, 15, pp. 3081 - 3094

Park SB; Lin CS-Y; Krishnan AV; Friedlander M; Goldstein D; Kiernan MC, 2008, 'Oxaliplatin-induced chronic changes in sensory nerve excitability', Clinical Neurophysiology, 119, pp. e22 - e22, http://dx.doi.org/10.1016/j.clinph.2007.10.044

Underhill CR; Goldstein D; Gorbounova VA; Biakhov MY, 2008, 'Randomized phase II trial of pemetrexed plus irinotecan (ALIRI) versus leucovorin-Modulated 5-FU plus Irinotecan (FOLFIRI) in first-line treatment of locally advanced or metastatic colorectal cancer', Oncology, 73, pp. 9 - 20

Ngan S; Fisher R; Mackay J; Solomon M; Burmeister B; Goldstein D; Schache D; Joseph D; Ackland S; McClure B, 2007, 'Acute adverse events in a randomised trial of short course versus long course preoperative radiotherapy for T3 adenocarcinoma of rectum: a Trans-Tasman Radiation Oncology Group trial (TROG 01.04)', EJC SUPPLEMENTS, 5, pp. 237 - 237, http://dx.doi.org/10.1016/S1359-6349(07)70936-9

Butow PN; Eisenbruch M; Goldstein D; Duggal-Beri P; Jefford M; Schofield P; Girgis A; King M, 2007, 'Unmet needs in Chinese, Greek and arabic speaking cancer patients in Australia', PSYCHO-ONCOLOGY, 16, pp. S77 - S78, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000249687400142&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Goldstein D; Underhill C, 2007, 'Regional cancer services in Australia: Some evidence of improvement but a long way to go', Cancer Forum, 31, pp. 67 - 69

Wilcken NR; Goldstein D; Nowak AK; Beale PJ; Jefford M; Dhillon H; O'Connell R; Heritier S; Simes RJ; Stockler M, 2007, 'A placebo-controlled trial of Sertraline's effects on symptoms, well-being and survival in advanced cancer: The ZEST Trial', Journal of Clinical Oncology, 25, pp. 9002 - 9002, http://dx.doi.org/10.1200/jco.2007.25.18_suppl.9002

Goldstein D; Shannon J; Brown C; Tebbutt N; Ackland S; Van Hazel G; Abdi E; Jefford M; Gainford MC; Adams K, 2007, 'ABC; An AGITG trial of fixed dose rate (FDR) gemcitabine (gem) and cisplatin for patients (pts) with advanced biliary tract cancer (ABC)', Journal of Clinical Oncology, 25, pp. 15015 - 15015, http://dx.doi.org/10.1200/jco.2007.25.18_suppl.15015

Schwartzberg LS; Hurwitz H; Stephenson J; Kotasek D; Goldstein D; Tebbutt N; McGreivy J; Sun Y; Yang L; Burris H, 2007, 'Safety and pharmacokinetics (PK) of AMG 706 with panitumumab plus FOLFIRI or FOLFOX for the treatment of patients (pts) with metastatic colorectal cancer (mCRC)', Journal of Clinical Oncology, 25, pp. 4081 - 4081, http://dx.doi.org/10.1200/jco.2007.25.18_suppl.4081

Leighl NB; Shepherd H; Butow P; Clarke SJ; McJannett M; Beale P; Wilcken N; Moore MJ; Chen EX; Tattersall MH; Goldstein D, 2007, 'When the goal is not cure: A randomized trial of a patient decision aid in advanced colorectal cancer', Journal of Clinical Oncology, 25, pp. 6509 - 6509, http://dx.doi.org/10.1200/jco.2007.25.18_suppl.6509

Stockler MR; O'Connell R; Nowak AK; Goldstein D; Turner J; Wilcken NR; Wyld D; Abdi EA; Glasgow A; Beale PJ; Jefford M; Dhillon H; Heritier S; Carter C; Hickie IB; Simes RJ, 2007, 'Effect of sertraline on symptoms and survival in patients with advanced cancer, but without major depression: a placebo-controlled double-blind randomised trial', Lancet Oncology, 8, pp. 603 - 612, http://dx.doi.org/10.1016/S1470-2045(07)70148-1

Yang JL; Qu XJ; Hayes V; Brenner PC; Russell PJ; Goldstein D, 2007, 'Erlotinib (OSI-774)-induced inhibition of transitional cell carcinoma of bladder cell line growth is enhanced by interferon-alpha', British Journal of Urology, 99, pp. 1539 - 1545

Clarke S; Goldstein D; Mitchell P; Michael M; Beale P; Friedlander ML, 2007, 'Modification of leucovorin dose within a simplified FOLFOX regimen improves tolerability without compromising efficacy', Clinical Colorectal Cancer, 6, pp. 578 - 582

Bennett BK; Goldstein D; Lloyd AROLA; Friedlander ML; Hickie IB, 2007, 'The experience of cancer-related fatigue and chronic fatigue syndrome: a qualitative and comparative study', Journal of Pain and Symptom Management, 34, pp. 126 - 135

Back to profile page